author-photo

Hiroyasu Muramatsu

Chugai Pharmaceutical Co.

10

Papers

119

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Novel myostatin-specific antibody enhances muscle strength in muscle disease models.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (6)
Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance

2016 Experimental Diabetes Research
Show All
- Source
- Cite
- Save
Citations (5)
Anticorps anti-myostatine, polypeptides contenant des variants de régions fc, et procédés d'utilisation

2015
Show All
- Source
- Cite
- Save
Citations (0)
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes

2008 Journal of Diabetes and Its Complications
Show All
- Source
- Cite
- Save
Citations (16)
Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits

2008 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (19)
Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools

2007 Neurogastroenterology and Motility
Show All
- Source
- Cite
- Save
Citations (16)